Epigenetics Market is Expected to Experience a Swift Development

1. Epigenetics Market Global Analysis and Forecast to 2028 Published Date : Jan 2019 Email: sales@theinsightpartners.com

2. Email: sales@theinsightpartners.com Report Studies  Epigenetics Market Forecast to 2025 – COVID-19 Impact and Global Analysis – by Product (Reagents, Kits, Enzymes, Instruments & Consumables, and Bioinformatics Tools), Technology (Histone Modification, DNA Methylation, and Others), Application (Oncology, Cardiovascular Diseases, and Others) End Users (Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Organization)  The Epigenetics Market is projected to reach US$ 2,611.57 million by 2025 from US$ 991.45 million in 2017; it is expected to grow at a CAGR of 13.6% from 2017 to 2025. 2

3. Email: sales@theinsightpartners.com Epigenetics Market Overview  The declining costs associated with different strategies and methods for sequencing supports to influence the scale and scope of almost all genomic research projects. The costs associated with DNA sequencing performed at the sequencing centers which is funded by the Institutes, has tracked by the National Human Genome Research Institute (NHGRI) for many years. This information has served as a key standard for establishing the DNA sequencing capacity and considering improvements in DNA sequencing technologies of the NHGRI Genome Sequencing Program (GSP). In the recent years, next generation sequencing price have declined substantially. For instance, first whole human genome sequencing cost over US$3.7 billion in 2000 and took 13 years for the completion. However, the costs for the same in recent years has reduced to US$1,000 and the process requires less number of days. In 2000, cost for sequencing was US$ 3.7 billion, which dropped down to US$ 10 million in 2006 and declined to US$ 5,000 in 2012. Major market players such as Illumina and Roche have introduced breakthrough technologies that have enabled in the cost and time reduction in the sequencing. Owing to factors such as advances in the field of genomics, development in different methods and strategies for sequencing, there is a notable decline in the cost of sequencing, that upsurge the growth of the market. 3

4. Email: sales@theinsightpartners.com Key Segment Market Segment By Type:-  By Product (Reagents, Kits, Enzymes, Instruments & Consumables, and Bioinformatics Tools)  Technology (Histone Modification, DNA Methylation, and Others)  Application (Oncology, Cardiovascular Diseases, and Others)  End-User (Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Organization) Download Sample Here 4

5. Email: sales@theinsightpartners.com $50,000 Epigenetics Market Value $40,000 $30,000 CAGR of $20,000 13.6% $10,000 (2017 - 2025) $0 20XX 20XX 20XX 20XX 20XX Download Sample 5

6. Email: sales@theinsightpartners.com Company Profiles  Merck KGaA  Thermo Fisher Scientific Inc.  ABCAM Plc  Agilent Technologies  Active Motif  Qiagen  Bio-Rad Laboratories, Inc.  Perkinelmer Inc.  New England Biolabs (NEB)  Illumina Inc. Download Sample Here 6

7. Email: sales@theinsightpartners.com By Geography  North America (the US, Canada, and Mexico)  Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe)  Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific)  Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa)  South & Central America (Brazil, Argentina, and the Rest of South & Central America). 7

8. THANK YOU! Phone : +1-646-491-9876 E-Mail : sales@theinsightpartners.com